삼성서울병원

Ko En

Hematology-Oncology Jung, Hyun Ae M.D

Expertise
Lung cancer, head and neck cancer, CNS tumor, molecular biology
Treament Schedule 05 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM
Treament Schedule 06 月
DATE
SAT
01
SUN
02
MON
03
TUE
04
WEB
05
THU
06
FRI
07
SAT
08
SUN
09
MON
10
TUE
11
WEB
12
THU
13
FRI
14
SAT
15
SUN
16
MON
17
TUE
18
WEB
19
THU
20
FRI
21
SAT
22
SUN
23
MON
24
TUE
25
WEB
26
THU
27
FRI
28
SAT
29
SUN
30
AM
PM

Medical Education

2012~2014 Ph.D. Sungkyunkwan University, School of Medicine, Seoul, Korea
2011~2012 MMS Sungkyunkwan University, School of Medicine, Seoul, Korea
2001~2007 MD Kyungpook National University, School of Medicine, Daegu, Korea

Post-Graduate Training

Fellowship   2013~2014 Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center
Residency   2008~2013 Department of Medicine, Samsung Medical Center
Internship   2007~2008 Samsung Medical Center

Professional Appointments

2022~Present Clinical Associate Professor Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center
2020~2021 Clinical Assistant Professor Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center
2018~2020 Clinical Instructor Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center

Professional Memberships

2015~Present Member IASCL International Association for the Study of Lung Cancer
2015~Present Member ASCO American Society of Clinical Oncology
2015~Present Member ESMO European Society for Medical Oncology
2015~Present Member KSMO Korean Soceity of Medical Oncology
2015~Present Member KCSG Korean Cancer Study Group

Selected Publications

  • CANCER 2021 10.1002/cncr.33571 High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean lung liquid versus invasive biopsy program Park1, S; Olsen, S; Ku, BM; Lee, MS; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Choi, YL; Ahn, MJ
    View PubMed
  • CANCERS 2021 10.3390/cancers13081913 Prognostic Value of the Neutrophil-to-Lymphocyte Ratio before and after Radiotherapy for Anaplastic Thyroid Carcinoma Park1, J; Park, J; Shin, JH; Oh, YL; Jung, HA; Chung, MK; Choe, JH; Ahn, YC; Kim, SW; Chung, JH; Kim, TH; Noh, JM
    View PubMed
  • KOREAN J INTERN MED 2021 10.3904/kjim.2019.385 Mutations in genes affecting DNA methylation enhances responses to decitabine in patients with myelodysplastic syndrome Jung1, HA; Jung, CW; Jang, JH
    View PubMed
  • J KOREAN NEUROSURG SOC 2021 10.3340/jkns.2020.0135 Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery Lee1, MH; Cho, KR; Choi, JW; Kong, DS; Seol, HJ; Nam, DH; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Ahn, MJ; Park, K; Lee, JI
    View PubMed
  • TRANSL LUNG CANCER R 2021 10.21037/tlcr-20-1128 Comprehensive evaluation of the clinical utility of plasma EGFR test in non-small cell lung cancer patients with acquired resistance to first-line EGFR inhibitors Kim1, H; Jung, HA; Lee, SH; Ahn, JS; Ahn, MJ; Park, K; Sun, JM
    View PubMed